IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $986 | -12.0% | 62,140 | +4.7% | 0.01% | -12.5% |
| Q2 2023 | $1,120 | +376.6% | 59,334 | -3.1% | 0.01% | +300.0% |
| Q1 2023 | $235 | -21.1% | 61,204 | +1.7% | 0.00% | 0.0% |
| Q4 2022 | $298 | -99.9% | 60,155 | -7.6% | 0.00% | 0.0% |
| Q3 2022 | $311,000 | +113.0% | 65,131 | +101.3% | 0.00% | +100.0% |
| Q2 2022 | $146,000 | -25.9% | 32,359 | -22.0% | 0.00% | 0.0% |
| Q1 2022 | $197,000 | -27.6% | 41,474 | +13.0% | 0.00% | 0.0% |
| Q4 2021 | $272,000 | +52.8% | 36,701 | +17.0% | 0.00% | 0.0% |
| Q3 2021 | $178,000 | +16.3% | 31,369 | +35.2% | 0.00% | 0.0% |
| Q2 2021 | $153,000 | -3.2% | 23,199 | +18.8% | 0.00% | 0.0% |
| Q1 2021 | $158,000 | +53.4% | 19,526 | +22.0% | 0.00% | 0.0% |
| Q4 2020 | $103,000 | +186.1% | 16,003 | +59.7% | 0.00% | – |
| Q3 2020 | $36,000 | -77.9% | 10,023 | -41.8% | 0.00% | -100.0% |
| Q3 2018 | $163,000 | -40.5% | 17,212 | -39.0% | 0.00% | -50.0% |
| Q2 2018 | $274,000 | -6.5% | 28,206 | +1.3% | 0.00% | 0.0% |
| Q1 2018 | $293,000 | +36.3% | 27,842 | -17.0% | 0.00% | +100.0% |
| Q4 2017 | $215,000 | +465.8% | 33,544 | +174.0% | 0.00% | – |
| Q2 2016 | $38,000 | -58.7% | 12,241 | +13.6% | 0.00% | -100.0% |
| Q1 2016 | $92,000 | -15.6% | 10,773 | +34.0% | 0.00% | 0.0% |
| Q4 2015 | $109,000 | +7.9% | 8,042 | -23.9% | 0.00% | 0.0% |
| Q3 2015 | $101,000 | +110.4% | 10,567 | +218.3% | 0.00% | – |
| Q2 2015 | $48,000 | +108.7% | 3,320 | +27.5% | 0.00% | – |
| Q1 2015 | $23,000 | +43.8% | 2,604 | +1.8% | 0.00% | – |
| Q4 2014 | $16,000 | -51.5% | 2,557 | -17.3% | 0.00% | – |
| Q3 2014 | $33,000 | -10.8% | 3,091 | -1.3% | 0.00% | – |
| Q2 2014 | $37,000 | -24.5% | 3,133 | -4.6% | 0.00% | – |
| Q1 2014 | $49,000 | +4.3% | 3,283 | +3.2% | 0.00% | – |
| Q4 2013 | $47,000 | -73.6% | 3,181 | -69.7% | 0.00% | -100.0% |
| Q3 2013 | $178,000 | +87.4% | 10,484 | +82.8% | 0.00% | +100.0% |
| Q2 2013 | $95,000 | – | 5,735 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |